Researchers quantify immune cells associated with future breast cancer risk

February 8, 2017, Mayo Clinic
Credit: Mayo Clinic

Researchers from Mayo Clinic have quantified the numbers of various types of immune cells associated with the risk of developing breast cancer. The findings are published in a study in Clinical Cancer Research.

"This is the first study to quantify the numbers of various immune cell types in breast tissue and whether they are associated with later risk," says the study's lead author, Amy Degnim, M.D., a at Mayo Clinic. "Our findings provide evidence that the immune system may have an important role in promoting or inhibiting breast cancer development in its very earliest stages." In addition, Dr. Degnim says the findings provide researchers with greater confidence that immune-related approaches to breast cancer prevention, such as vaccines, may be useful.

Dr. Degnim and her colleagues studied quantitative differences in immune cell types between normal breast tissue from donors and breast tissue from donors with benign breast disease, a non-cancerous lump or thickening of breast tissue. They designed a breast tissue matched case control study using samples from the Susan G. Komen for the Cure Tissue Bank and women diagnosed with benign breast disease at Mayo Clinic who subsequently developed cancer or remained cancer-free.

Researchers found that, compared to normal breast tissue, breast tissue with benign breast disease had greater numbers of several types of immune cells, especially dendritic cells and macrophages that work together to create an immune response, says Dr. Degnim. She says women who later developed breast cancer showed lower amounts of antibody-producing , known as B cells, in their , which supports the hypothesis that the immune system may play an important role in early breast cancer development.

Explore further: New breast cancer risk prediction model more accurate current model

More information: Amy C. Degnim et al. Alterations in the Immune Cell Composition in Premalignant Breast Tissue that Precede Breast Cancer Development, Clinical Cancer Research (2017). DOI: 10.1158/1078-0432.CCR-16-2026

Related Stories

New breast cancer risk prediction model more accurate current model

January 26, 2015
A new breast cancer risk prediction model combining histologic features of biopsied breast tissue from women with benign breast disease and individual patient demographic information more accurately classified breast cancer ...

Researchers identify breast microbiome/bacterial differences between healthy and cancerous tissue

August 3, 2016
A team of Mayo Clinic researchers has identified evidence of bacteria in sterilely-obtained breast tissue and found differences between women with and without breast cancer. The findings are published in the Aug. 3 issue ...

Inbuilt body clocks link breast stiffness to cancer risks

January 31, 2017
University of Manchester biologists have discovered that breast tissues have 24-hour body clocks, and that several hundred genes are regulated in a daily cycle.

Breast cancer awareness: What women need to know

September 28, 2016
As national Breast Cancer Awareness Months begins next week, breast health expert Dr. Sharon Koehler of New York Institute of Technology College of Osteopathic Medicine, says women need to know the following five things:

3-D imaging improves breast cancer screening

November 9, 2016
What if breast cancers could be found earlier, lumps seen more clearly or the number of callbacks reduced? Three-dimensional breast imaging technology can do just that by increasing the accuracy of breast cancer screening ...

Research helps refine role of gene variants in breast cancer risk

December 7, 2016
Inherited pathogenic variants in protein coding genes BARD1 and RAD51D increase a woman's likelihood of developing breast cancer, according to research conducted at Mayo Clinic and presented today at the 2016 San Antonio ...

Recommended for you

Single-cell study in a childhood brain tumor affirms the importance of context

April 20, 2018
In defining the cellular context of diffuse midline gliomas, researchers find the cells fueling their growth and suggest a potential approach to treating them: forcing their cells to be more mature.

Aggressive breast cancer already has resistant tumour cells prior to chemotherapy

April 20, 2018
Difficult to treat and aggressive "triple-negative" breast cancer is chemoresistant even before chemotherapy begins, a new study by researchers from Karolinska Institutet and the University of Texas MD Anderson Cancer Center ...

Mechanism that drives development of liver cancer brought on by non-alcoholic fatty liver disease discovered

April 19, 2018
A team of researchers from several institutions in China has found a mechanism that appears to drive the development of a type of liver cancer not caused by alcohol consumption. In their paper published in the journal Science ...

Discovery adds to evidence that some children are predisposed to develop leukemia

April 19, 2018
St. Jude Children's Research Hospital researchers have made a discovery that expands the list of genes to include when screening individuals for possible increased susceptibility to childhood leukemia. The finding is reported ...

Scientists identify 170 potential lung cancer drug targets using unique cellular library

April 19, 2018
After testing more than 200,000 chemical compounds, UT Southwestern's Simmons Cancer Center researchers have identified 170 chemicals that are potential candidates for development into drug therapies for lung cancer.

Chip-based blood test for multiple myeloma could make bone biopsies a relic of the past

April 19, 2018
The diagnosis and treatment of multiple myeloma, a cancer affecting plasma cells, traditionally forces patients to suffer through a painful bone biopsy. During that procedure, doctors insert a bone-biopsy needle through an ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.